Trump’s main effort, which he cited on August 3, centers on getting drugmakers to offer the same price in the US as they do in Europe and other peer countries, the so-called “Most Favored Nation” ...

The only two approved treatments for Alzheimer’s that can slow progression—developed by Eli Lilly and Biogen-Eisai—work by removing amyloid plaque. They reduce cognitive dec ...

SEED Therapeutics, Inc. ("SEED”), a clinical-stage biotechnology company pioneering rational molecular glue degraders for ...

Novel PARG inhibitor FORX-428 has shown best-in-class characteristics in preclinical studiesTrial initially taking place in the U.S., following IND clearanceInitial data expected in mid-2026 from open ...

Britain's blue-chip index climbed on Monday, led by healthcare and consumer shares, but losses in defence stocks ahead of ...

GSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...

Toxic residues in coffee are minimal, according to a new investigation. Still, there are a few areas of concern.

The tumor, which occurs when supportive cells in the brain grow and divide uncontrollably, is extremely aggressive and deadly. Most patients survive only 14 to 16 months after diagnosis.

The Trump administration’s anti-regulatory approach and cost-cutting moves risk unraveling the system of checks and balances ...

Louisiana's fight with New York over abortion pills could go before the U.S. Supreme Court and may help define the legal ...

Because of the unglamorous, underfunded, lifesaving work of the World Health Organization, the National Institutes of Health, ...

British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...